IGF-1LR3 (0.1mg / 1mg) appears in Growth Research catalogs for qualified buyers who need specification, COA, and RUO clarity—IGF-1LR3 Catalog Comparison Notes summarizes key checks.
IGF-1LR3 is a long-arginine analog of insulin-like growth factor 1 used in laboratory research on IGF-1 receptor signaling, protein analog behavior, cell-growth pathway models, and peptide structure-activity studies.
Muscle cell differentiation studies cite LR3 analogs when IGFBP interference must be minimized in serum-free experimental systems. IGF-1 LR3 contains an arginine substitution at position 3 and a 13-amino-acid extension reducing IGF-binding protein affinity, prolonging receptor engagement in cell culture.
Research examines PI3K–Akt and MAPK pathway phosphorylation time courses in myoblast and fibroblast lines treated with LR3 versus native IGF-1. Receptor autophosphorylation assays, cell proliferation curves, and apoptosis markers (cleaved caspase-3) are common endpoints.
Related Growth Research items include CJC-1295 with DAC, CJC-1295 (no DAC), CJC1295(no DAC)&IPA, HCG. Export spec fields before leadership approval. Single-peptide and blend formats serve different experimental designs; confirm protocol needs before selecting IGF-1LR3.
Catalog comparison: Compare IGF-1LR3 (0.1mg / 1mg) on vial format, documented purity, and COA access—not product name alone.
Catalog identifiers for IGF-1LR3: CAS 946870-92-4, Formula: C400H625N111O115S9. MW Approx. 9.1 kDa, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Listed formats for IGF-1LR3: 0.1mg10vials, 1mg10vials. Quote emails should include Cat No. (IG01, IG1) so delivered vials match protocol design.
When citing external effect sizes for IGF-1LR3, match mg strength to published studies.
Price-per-mg comparisons for IGF-1LR3 should include documentation and shipping—not vial price alone.
Catalog comparison for IGF-1LR3 within Growth Research should export specification fields into a spreadsheet: mg strength, Cat No., purity target, COA availability, and format. Leadership reviews proceed faster with aligned columns than with sequential product tabs. IGF-1LR3 (0.1mg / 1mg) may compete with single-peptide and blend SKUs in the same research direction. Match protocol design—factorial versus monotherapy—before selecting a catalog line; blends cannot be deconvolved post hoc without separate vials.
Literature effect sizes for IGF-1LR3 experiments often cite specific mg strengths. When comparing suppliers, align delivered specification with published methods—not approximate product names. Price-per-mg analysis for IGF-1LR3 should include documentation access, shipping cost, and repeat-order batch continuity—not headline vial price alone.
Peer products in Growth Research may differ by receptor target or sequence length even when names sound similar. Mechanism fit review precedes price comparison for IGF-1LR3.
Price-per-mg analysis for IGF-1LR3 should include documentation access, shipping cost, and repeat-order batch continuity—not headline vial price alone. Peer products in Growth Research may differ by receptor target or sequence length even when names sound similar. Mechanism fit review precedes price comparison for IGF-1LR3.
Literature effect sizes for IGF-1LR3 experiments often cite specific mg strengths. When comparing suppliers, align delivered specification with published methods—not approximate product names.
Peer products in Growth Research may differ by receptor target or sequence length even when names sound similar. Mechanism fit review precedes price comparison for IGF-1LR3. Catalog comparison for IGF-1LR3 within Growth Research should export specification fields into a spreadsheet: mg strength, Cat No., purity target, COA availability, and format. Leadership reviews proceed faster with aligned columns than with sequential product tabs.
IGF-1LR3 (0.1mg / 1mg) may compete with single-peptide and blend SKUs in the same research direction. Match protocol design—factorial versus monotherapy—before selecting a catalog line; blends cannot be deconvolved post hoc without separate vials. Literature effect sizes for IGF-1LR3 experiments often cite specific mg strengths. When comparing suppliers, align delivered specification with published methods—not approximate product names.
Price-per-mg analysis for IGF-1LR3 should include documentation access, shipping cost, and repeat-order batch continuity—not headline vial price alone.
IGF-1LR3 from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.